Vendor profile
JANSSEN CILAG FARMACEUTICA, LDA
PT- Awards
- 61
- Total awarded value
- €1,352,177,270
- Countries
- Portugal
- Latest award
- Jul 10, 2026
- Expiring within 12 months
- 0
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 07/10/2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - DARATUMUMAB - 3 MESES | Pharmaceuticals | €458.3K | PT | — | View on TED ↗ |
| 06/24/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 2023/0491 - IBRUTINIB [420 MG CÁP/COMP] | — | €454.1K | PT | — | View on TED ↗ |
| 05/21/2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - DARATUMUMAB - 3 MESES | — | €458.3K | PT | — | View on TED ↗ |
| 05/12/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS] | — | €2.3M | PT | — | View on TED ↗ |
| 05/12/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 261G000583 - C.Central Medicamentos 2026 - 2026/0263 - BEDAQUILINA | — | €371.7K | PT | — | View on TED ↗ |
| 04/13/2026 | Unidade Local de Saúde Gaia/Espinho, E.P.E. | Portugal – Pharmaceutical products – 1015426 Aquisição de Medicamentos Exclusivos Janssen Cilag - Ustecinumab - 2026 | — | €400.5K | PT | — | View on TED ↗ |
| 03/30/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 261G000411 - C.Central Medicamentos 2026 - 2026/0192 - USTECINUMAB | — | €532.2K | PT | — | View on TED ↗ |
| 03/25/2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – ANTIANDROGENIOS - APALUTAMIDA - 1º TRIMESTRE | — | €285.0K | PT | — | View on TED ↗ |
| 03/20/2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - DARATUMUMAB - 1º SEMESTRE | — | €666.6M | PT | — | View on TED ↗ |
| 03/06/2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – ANTIANDROGENIOS - APALUTAMIDA - 1º SEMESTRE | — | €647.0M | PT | — | View on TED ↗ |
| 01/29/2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 261G000180-C.Central Medicamentos - 2026/0126 - BEDAQUILINA | — | €72.9K | PT | — | View on TED ↗ |
| 12/16/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS] | — | €2.5M | PT | — | View on TED ↗ |
| 12/02/2025 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - DARATUMUMAB - 2º SEMESTRE | — | €458.3K | PT | — | View on TED ↗ |
| 12/02/2025 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – ANTIANDROGENIOS - APALUTAMIDA - 2º SEMESTRE | — | €469.4K | PT | — | View on TED ↗ |
| 12/01/2025 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - DARATUMUMAB | Pharmaceuticals | €458.3K | PT | — | View on TED ↗ |
| 10/28/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 251G001459 -USTECINUMAB 45 MG SOL INJ | — | €321.3K | PT | — | View on TED ↗ |
| 08/19/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- IBRUTINIB [140 MG; CÁP/COMP] | — | €244.3K | PT | — | View on TED ↗ |
| 08/19/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- IBRUTINIB [140 MG; CÁP/COMP] | — | €53.4K | PT | — | View on TED ↗ |
| 08/05/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - GUSELCUMAB [100 MG/1 ML; SOL INJ; CANETA] | — | €49.5K | PT | — | View on TED ↗ |
| 08/05/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - GUSELCUMAB [100 MG/1 ML; SOL INJ; CANETA] | — | €247.4K | PT | — | View on TED ↗ |
| 08/05/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - GUSELCUMAB [100 MG/1 ML; SOL INJ; CANETA] | — | €49.5K | PT | — | View on TED ↗ |
| 07/30/2025 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES - DARATUMUMAB | — | €458.3K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GOLIMUMAB [50 MG/0.5 ML; SOL INJ; CANETA/SERINGA] | Pharmaceuticals | €139.9K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- IBRUTINIB [560 MG; CÁP/COMP] | — | €133.6K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- GOLIMUMAB [50 MG/0.5 ML; SOL INJ; CANETA/SERINGA] | Pharmaceuticals | €664.5K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491- IBRUTINIB [560 MG; CÁP/COMP] | — | €634.7K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the cardiovascular system – 2023/0481- MACITENTANO [10 MG; CÁP/COMP] | Pharmaceuticals | €123.7K | PT | — | View on TED ↗ |
| 07/01/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the cardiovascular system – 2023/0481- MACITENTANO [10 MG; CÁP/COMP] | Pharmaceuticals | €123.7K | PT | — | View on TED ↗ |
| 06/17/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900-DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP] (D559) | — | €710.4K | PT | — | View on TED ↗ |
| 06/17/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900-DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP] (D559) | — | €142.1K | PT | — | View on TED ↗ |
| 06/11/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900-DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] (D542) | — | €179.9K | PT | — | View on TED ↗ |
| 06/11/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 2024/0900-DARUNAVIR + COBICISTATE [800 MG + 150 MG; CÁP/ COMP] (D542) | — | €854.6K | PT | — | View on TED ↗ |
| 06/11/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - APALUTAMIDA [60 MG; CÁP/ COMP] | — | €1.5M | PT | — | View on TED ↗ |
| 06/11/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - APALUTAMIDA [60 MG; CÁP/ COMP] | — | €290.5K | PT | — | View on TED ↗ |
| 05/07/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 251G000808 - C.Central Medicamentos-1491/2025 | — | €1.8M | PT | — | View on TED ↗ |
| 04/23/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - IBRUTINIB [420 MG; CÁP/COMP] (I1159) | — | €501.1K | PT | — | View on TED ↗ |
| 04/23/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - IBRUTINIB [420 MG; CÁP/COMP] (I1159) | — | €2.4M | PT | — | View on TED ↗ |
| 04/15/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the nervous system – 2023/0491 - DARATUMUMAB [120 MG/ ML; 15 ML; SOL INJ; FRS] (D575) | — | €6.0M | PT | — | View on TED ↗ |
| 04/15/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the nervous system – 2023/0491 - DARATUMUMAB [120 MG/ ML; 15 ML; SOL INJ; FRS] (D575) | — | €200.0K | PT | — | View on TED ↗ |
| 04/15/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the nervous system – 2023/0491 - DARATUMUMAB [120 MG/ ML; 15 ML; SOL INJ; FRS] (D575) | — | €999.9K | PT | — | View on TED ↗ |
| 04/08/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 251G000353-USTECINUMAB 90 MG SOL INJ SERINGA | — | €433.3K | PT | — | View on TED ↗ |
| 04/08/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 251G000352-USTECINUMAB 45 MG SOL INJ | — | €321.3K | PT | — | View on TED ↗ |
| 03/27/2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 251G000482 - C.Central Medicamentos - 1358/2025 | — | €896.4K | PT | — | View on TED ↗ |
| 02/25/2025 | Unidade Local de Saúde Gaia/Espinho, E.P.E. | Portugal – Pharmaceutical products – 1041425 Aquisição Medicamentos Exclusivos Janssen Cilag – Ustecinumab - Ano 2025 | — | €661.5K | PT | — | View on TED ↗ |
| 12/17/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (I1159) | — | €245.5K | PT | — | View on TED ↗ |
| 12/17/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (A23138) | — | €308.3K | PT | — | View on TED ↗ |
| 12/17/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (I1159) | — | €445.9K | PT | — | View on TED ↗ |
| 12/17/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (A23138) | — | €1.1M | PT | — | View on TED ↗ |
| 12/17/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (A23138) | — | €225.1K | PT | — | View on TED ↗ |
| 12/17/2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (I1159) | — | €2.2M | PT | — | View on TED ↗ |